Lyophilized Injectable Drugs Market, 2024 - Key Therapeutic Sector Analysis and Market Data
Comunicato Precedente
Comunicato Successivo
The inherent instability of protein drugs is a limitation that has a direct impact on the drug delivery sector. Therapeutic proteins must either be stored under special conditions or formulated to retain their efficacy from the time of manufacture until they are dispensed. Liquid protein drugs require refrigeration until dispensed - a requirement referred to as the cold chain'. Alternatively, proteins can be formulated as powders (lyophilization). Lyophilized proteins must be reconstituted prior to injection. Lyophilized drugs are sold with reconstitution vial systems, or packaged in special injection devices (e.g., pens, needle-free injectors, two-part syringes) that allow reconstitution to take place in the device prior to injection.
What You Will Learn
Report Value Chain - Who Should Read this Report
Development
Industry
Market
Key Topics Covered:
Executive Summary
The Market Opportunity
Delivery Market Dynamics
Lyophilized Drugs - Primary Packaging
Lyophilized Drugs - Reconstitution and Delivery
Lyophilized Drugs - Key Therapeutic Sector Analysis and Market Data
Market Factors
Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/qlln28/lyophilized
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
